$MDWD

Rubinstein Samuel purchased $7K of MDWD (indirect holdings)

Rubinstein Samuel purchased 525 indirectly-held shares of MediWound Ltd. (MDWD) at $12.62 on 2026-09-01.

Original reporting
SEC EDGAR · Rubinstein Samuel
Published Sep 2, 2026, 8:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 8:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$MDWD
Neutral
low confidence
Mentioned
$MDWD
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MDWDNeutralLow
01

Why it matters

The transaction is small relative to typical market volume and likely has negligible effect on MDWD's price.

02

Market read

Limited relevance; primarily of interest to investors tracking insider activity.

03

What to watch

Potential upcoming clinical data or regulatory events not disclosed.

Relevance 3/10Novelty 4/10Timing: post‑market 2026‑09‑01

Background

Form 4 filings disclose insider trades; this filing reports a director's purchase.

Company-level read

Ticker impact

$MDWDNeutralLow confidence
Context

Director Rubinstein Samuel bought 525 shares for $6,625.50 in a Form 4 filing.

Expected impact

Minimal price movement expected.

Evidence & confidence

Purchase size is modest ($6.6k) and unlikely to move the stock significantly.

Market effects

None

None

None

Counterpoint

Insider purchase could be routine compensation rather than a strong bullish signal.

Key entities

  • MediWound Ltd.

    Biotech firm listed under ticker MDWD.

  • Rubinstein Samuel

    Director of MediWound Ltd. who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MDWDMed

MediWound Ltd. (MDWD): Financial results for Q2 2026

MediWound Ltd. (MDWD) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 MediWound Reports Second Quarter 2026 Financial Results and Provides Corporate Update EscharEx ® Phase III VALUE Trial Advancing; Interim Assessment and Enrollment Completion Expected by End of First Quarter 2027 Master Services Agreement Signed with Vericel Under it

$DELLLow

Silver Lake Partners IV, L.P. (Durban Egon) sold $29.2M of DELL (indirect holdings)

Silver Lake Partners IV, L.P. sold 51,494 indirectly-held shares of Dell Technologies Inc. (DELL) at an average of $567.88 ($561.56–$573.28, $29.24M total) across 13 trades on 2026-09-16. Filed jointly with Silver Lake Technology Associates IV, L.P. (Director), SLTA IV (GP), L.L.C. (Director), Silver Lake Group, L.L.C. (Director) and Durban Egon (Director).